Literature DB >> 29671615

Patient-reported Outcomes for the Detection, Quantification, and Evaluation of Chronic Obstructive Pulmonary Disease Exacerbations.

Alex J Mackay1,2, Konstantinos Kostikas3, Lindsey Murray4, Fernando J Martinez5, Marc Miravitlles6, Gavin Donaldson1, Donald Banerji7, Francesco Patalano3, Jadwiga A Wedzicha1.   

Abstract

An exacerbation of chronic obstructive pulmonary disease (COPD) is an acute worsening of respiratory symptoms accompanied by a variable degree of physiological deterioration. The traditional assessment of an exacerbation consists of the reporting of symptoms by the patient to a clinician and subsequent clinical assessment. It would be valuable to also gather symptom reports directly from patients, and thus patient-reported outcome (PRO) tools should be ideally suited to the evaluation of COPD exacerbations. However, most pharmaceutical industry- and large academy-sponsored studies have used a healthcare resource use definition alone, which is based on sustained worsening of a patient's condition from the stable state that requires a change in regular medication. This Review explores the use of PROs for the detection, quantification, and evaluation of COPD exacerbations. It examines symptom diary cards as exacerbation detection tools and their evolution into electronic diaries used in pharmaceutical trials. This paper also describes the development of specifically designed PROs that have been used in exacerbation settings, focusing on the Exacerbations and Symptoms in COPD e-Diary, Exacerbations of Chronic Obstructive Pulmonary Disease Tool, COPD Assessment Test, and Chronic Respiratory Disease Questionnaire, highlighting the strengths and weaknesses of these instruments. We describe the effectiveness of these tools to enhance exacerbation reporting; quantify exacerbation characteristics, including the frequency, duration, and severity of events; and evaluate the outcome. We also explore the potential use of PROs in future studies to discriminate the effect of therapies on different exacerbation phenotypes and thus enhance personalized therapeutic approaches.

Entities:  

Keywords:  Exacerbations of Chronic Obstructive Pulmonary Disease Tool (EXACT); chronic obstructive pulmonary disease; exacerbations; healthcare resource use; patient-reported outcomes

Mesh:

Year:  2018        PMID: 29671615     DOI: 10.1164/rccm.201712-2482CI

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  11 in total

1.  Higher COPD Assessment Test Score Associated With Greater Exacerbations Risk: A Post Hoc Analysis of the IMPACT Trial.

Authors:  Byron Thomashow; Marjorie Stiegler; Gerard J Criner; Mark T Dransfield; David M G Halpin; MeiLan K Han; Peter Lange; Fernando J Martinez; Dawn Midwinter; Dave Singh; Maggie Tabberer; Robert A Wise; David A Lipson; Paul Jones
Journal:  Chronic Obstr Pulm Dis       Date:  2022-01-27

2.  Assessment of the COPD Assessment Test Within U.S. Primary Care.

Authors:  Richard H Stanford; Maggie Tabberer; Mark Kosinski; Phaedra T Johnson; John White; Maureen Carlyle; Nicole A Tillery
Journal:  Chronic Obstr Pulm Dis       Date:  2020-01

3.  Impact of baseline symptoms and health status on COPD exacerbations in the FLAME study.

Authors:  Alexander J Mackay; Konstantinos Kostikas; Nicolas Roche; Stefan-Marian Frent; Petter Olsson; Pascal Pfister; Pritam Gupta; Francesco Patalano; Donald Banerji; Jadwiga A Wedzicha
Journal:  Respir Res       Date:  2020-04-22

Review 4.  Towards precision in defining COPD exacerbations.

Authors:  Christine R Jenkins
Journal:  Breathe (Sheff)       Date:  2021-09

5.  Impact of Lung Function and Exacerbations on Health-Related Quality of Life in COPD Patients Within One Year: Real-World Analysis Based on Claims Data.

Authors:  Alisa Stöber; Johanna I Lutter; Larissa Schwarzkopf; Florian Kirsch; Anja Schramm; Claus F Vogelmeier; Reiner Leidl
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-09-21

Review 6.  Is It Time to Change the Definition of Acute Exacerbation of Chronic Obstructive Pulmornary Disease? What Do We Need to Add?

Authors:  Maria Montes de Oca; Maria Eugenia Laucho-Contreras
Journal:  Med Sci (Basel)       Date:  2018-06-14

Review 7.  Definition, Causes, Pathogenesis, and Consequences of Chronic Obstructive Pulmonary Disease Exacerbations.

Authors:  Andrew I Ritchie; Jadwiga A Wedzicha
Journal:  Clin Chest Med       Date:  2020-09       Impact factor: 2.878

8.  Compliance and Utility of a Smartphone App for the Detection of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease: Cohort Study.

Authors:  Juan Luis Rodriguez Hermosa; Antonia Fuster Gomila; Luis Puente Maestu; Carlos Antonio Amado Diago; Francisco Javier Callejas González; Rosa Malo De Molina Ruiz; Manuel E Fuentes Ferrer; Jose Luis Álvarez Sala-Walther; Myriam Calle Rubio
Journal:  JMIR Mhealth Uhealth       Date:  2020-03-19       Impact factor: 4.773

Review 9.  Patient-Reported Outcomes (PROs) in COPD Clinical Trials: Trends and Gaps.

Authors:  Nuzhat Afroz; Florian S Gutzwiller; Alex J Mackay; Christel Naujoks; Francesco Patalano; Konstantinos Kostikas
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-07-23

10.  Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study.

Authors:  Maggie Tabberer; C Elaine Jones; Sally Kilbride; David M G Halpin; David A Lomas; Steven Pascoe; Dave Singh; Robert A Wise; Gerard J Criner; Peter Lange; Mark T Dransfield; MeiLan K Han; Fernando J Martinez; Morrys C Kaisermann; David A Lipson
Journal:  Adv Ther       Date:  2020-07-09       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.